San Diego, CA -- (SBWIRE) -- 12/08/2023 -- An investigation on behalf of current long-term investors in shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) concerning potential breaches of fiduciary duties by certain directors and officers of BioXcel Therapeutics, Inc. was announced.

Investors who are current long term investors in BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: BTAI stocks follows a lawsuit filed against BioXcel Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: BTAI stocks, concerns whether certain BioXcel Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint the plaintiff alleges that, the Defendants failed to disclose to investors that the Company lacked adequate internal controls over protocol adherence and data integrity, that, as a result, the Company's principal investigator failed to adhere to the informed consent form approved by the Institutional Review Board, that the Company's principal investigator failed to maintain adequate case histories for certain patients whose records were reviewed by the FDA, that the Company's principal investigator fabricated email correspondence with a pharmacovigilance safety vendor that was then provided to the FDA, that the foregoing would negatively impact the Company's ability to obtain regulatory approval of BXCL501 for the treatment of agitation associated with dementia in patients with probable Alzheimer's disease, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.